Post-stem cell transplant maintenance in FLT3<sup>mut</sup> acute myeloid leukemia - A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib.

导出 LinkOut

翻译打印收藏纠错

第一作者： Karam,Ashouri

第一单位： University of Southern California Keck School of Medicine Los Angeles California USA.

作者： Karam,Ashouri ^[1] ; Krithika,Chennapan ^[1] ; Anastasia,Martynova ^[1] ; Samvel,Nazaretyan ^[1] ; Amir,Ali ^[2] ; Anush Aram,Ginosyan ^[1] ; Eric,Tam ^[2] ; Abdullah,Ladha ^[2] ; Karrune,Woan ^[2] ; Preet,Chaudhary ^[2] ; Imran,Siddiqi ^[3] ; George,Yaghmour ^[2]

作者单位： University of Southern California Keck School of Medicine Los Angeles California USA. ^[1] Internal Medicine Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases University of Southern California Norris Comprehensive Cancer Center Los Angeles California USA. ^[2] Department of Pathology University of Southern California Keck School of Medicine Los Angeles California USA. ^[3]

关键词 AML FMS‐like tyrosine kinase 3 (FLT3) inhibitor HSCT gilteritinib maintenance midostaurin

DOI 10.1002/jha2.885

PMID 38633126

发布时间 2024-06-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

EJHaem

2024年5卷2期

423-427页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Post-stem cell transplant maintenance in FLT3<sup>mut</sup> acute myeloid leukemia - A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib.

EJHaem

相似文献

EJHaem

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Post-stem cell transplant maintenance in FLT3<sup>mut</sup> acute myeloid leukemia - A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib.

EJHaem

相似文献

EJHaem

相关期刊

检索历史清除